Your Article Summary
The relationship between inflammation and new bone formation in patients with ankylosing spondylitis
Arthritis Research & Therapy, 09/05/08
Baraliakos X et al. – In patients with ankylosing spondylitis (AS), treated with anti-TNF agents, linkage and some dissociation of inflammation and new bone formation was found. More effective suppression of spinal inflammation may be required to inhibit structural damage in ankylosing spondylitis.
Methods- Study to investigate whether and how spinal inflammation is associated with new bone formation in AS
- Spinal MRI and conventional radiographs from 39 AS pts treated with anti-TNF agents at baseline and after 2 yrs were analysed
- 922 vertebral edges at the cervical and lumbar spine were analysed
- At baseline, the proportion of vertebral edges with and w/o inflammation that showed structural changes was similar
- From the perspective of syndesmophyte formation after 2 yrs, there were more vertebral edges w/o than with inflammation at baseline
- From the perspective of spinal inflammation at baseline more syndesmophytes developed at vertebral edges with than w/o inflammation
- Inflammation persisted in 31% of the initially inflamed vertebral edges, and new lesions developed in 8% of the vertebral edges w/o inflammation at baseline
- From the perspective of spinal inflammation after 2 yrs, 5.6% of the vertebral edges showed syndesmophyte development, vs 1.9% of the vertebral edges with new syndesmophytes w/o inflammation
Related Articles
Evaluation of inflammation and oxidative stress in ankylosing spondylitis: a role for macrophage migration inhibitory factor
Modern Rheumatology, 10/05/09
Relevance Score: 45%
Use of a Percutaneous Diskectomy Device to Facilitate the Diagnosis of Infectious Spondylitis
American Journal of Neuroradiology, 11/13/09
Relevance Score: 43%
Erythrocyte sedimentation rate, CRP level, and serum amyloid a protein for patient selection and monitoring of anti-tumor necrosis factor treatment in ankylosing spondylitis
Arthritis Care and Research, 11/02/09
Relevance Score: 43%
A 2-year comparative open label randomized study of efficacy and safety of etanercept and infliximab in patients with ankylosing spondylitis
Rheumatology International, 10/27/09
Relevance Score: 43%
Recent studies on the genetic basis of ankylosing spondylitis
Current Rheumatology Reports, 10/09/09
Relevance Score: 43%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Serum blc/cxcl13 concentrations and renal expression of cxcl13/cxcr5 in patients with systemic lupus erythematosus and lupus nephritis
Journal of Rheumatology, 12/06/09
Increased mRNA expression of collagen V gene in pulmonary fibrosis of systemic sclerosis
European Journal of Clinical Investigation, 12/04/09
The immunoregulatory role of vitamins A, D and E in patients with primary Sjogren's syndrome
Rheumatology, 12/01/09
Today in Spondylarthropathies...keeping you current
Receive free subspecialty "5-minute updates" via email
An epidemiological survey of low back pain and axial spondyloarthritis in a Chinese Han population
Scandinavian Journal of Rheumatology , 11/24/09
The chromosome 16q region associated with ankylosing spondylitis includes the candidate gene TRADD (TNF receptor type 1-associated death domain)
Annals of Rheumatic Diseases, 11/13/09

See Latest Articles